Jennifer Payne, MD
Psychiatry · Charlottesville, VANPI 1689614604
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $32,826 of the $42,595 with a category attached, or 77.1%. 6 manufacturers reported payments, led by Sage Therapeutics, LLC at 35.2% of the total. Reporting peaked in 2019 at $12,668 and has fallen 74.4% since, to $3,243 in 2025. Among psychiatry clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $1092.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$15K
- Johnson & Johnson$13K
- Biogen$10K
- Merck$3K
- Medela LLC$2K
- Acadia Pharmaceuticals Inc$145
What the payments were for
- Consulting fees$32,82677%
- Speaking & faculty fees$6,96816%
- Travel & lodging$2,2435%
- Food & beverage$5581%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sage Therapeutics, LLC | 11 | $14,997 |
| Johnson & Johnson | 16 | $12,668 |
| Biogen | 3 | $10,494 |
| Merck | 1 | $2,790 |
| Medela LLC | 1 | $1,500 |
| Acadia Pharmaceuticals Inc | 7 | $145 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,595 in reported general payments places this provider in the 95th percentile of 884 psychiatry providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 12 | $445 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 21 | $391 |
| Bupropion XlBupropion Hcl | 21 | $299 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Charlottesville
- Anita ClaytonCharlottesville$260K
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
- Kent McDanielGlen Allen$2.1M
- Jasdeep MiglaniManassas$958K
- David SpiegelNorfolk$565K
- William YetterVirginia Beach$312K
- Robert GardellaStaunton$201K
- Timothy KaneStaunton$162K
- Ralph McKenzieRoanoke$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.